Fliplab Competitors

Digital Foundry is a boutique software engineering firm headquartered in Tiburon, California. For more than 30 years, we have partnered with enterprise organizations and government agencies to design, build, and modernize complex digital systems. We specialize in the software that off-the-shelf tools can't solve and that large consulting firms struggle to deliver: mission-critical enterprise platforms, AI-enabled product systems, and the modernization of aging infrastructure that organizations depend on every day. What We Build Our core work spans five areas: custom enterprise software development, AI-enabled platform and agent system development, legacy system modernization, cloud-native platform engineering, and technical strategy and architecture consulting. We build enterprise web applications, data platforms, API ecosystems, operational tools, LLM-powered interfaces, AI copilots, agentic software systems, and complex workflow automation platforms. We are increasingly focused on practical AI — building systems designed for production, not experimental settings. How We Work We operate with senior-led teams. Every engagement is led by experienced engineers and architects who take direct accountability for outcomes. Projects range from focused 4–12 week discovery and architecture engagements to multi-year platform development programs. Who We Work With Our clients are Fortune 1000 enterprises and government agencies across financial services, healthcare, energy and utilities, logistics, manufacturing, and the public sector. Representative clients include JPMorgan Chase, GEICO, Blue Cross Blue Shield, General Electric, National Grid, Comcast, Disney, American Express, and Visa. We are typically engaged when programs are high-stakes, technically complex, or when prior efforts have stalled. Digital Foundry: trusted engineering for complex digital systems.

At NextGen Laboratories, we take pride in our ability to offer you high impact diagnostic results derived from next generation technologies. But we take it one step further – our dedicated staff provides personalized customer service to every patient.

APEX is a patient-driven pharmaceutical company focused on optimizing the standard of mental health care with psilocybin by bringing data supported, clinically evaluated drugs to market for depression and anxiety in PTSD. Our strategy is focused on developing pharmaceutical products through a phased clinical program evaluating safety and efficacy across multiple indications, alongside a robust early access program. APEX has two GMP Certified drug assets. APEX-52 is microdose synthetic psilocybin for clinical evaluation, currently in active phase 2b trials, and APEX-25 is the company’s macro dose drug asset, developed for in-clinic dosing with assisted psychotherapy. APEX recently launched North America’s first take-home psilocybin trial, and received approval for the world’s largest psilocybin clinical trial to-date both evaluating APEX-52 in the treatment of anxiety and depression in diagnosed PTSD. APEX is driven by an experienced and passionate leadership team from the Veteran community, healthcare, drug policy and emerging sectors who want to make a difference and disrupt the $380+ billion global mental health market. Find out more at apexlabs.com